Collplant announces uplisting to the nasdaq global market® and transition to trading of ordinary shares instead of adss

Rehovot, israel, may 25, 2021 /prnewswire/ -- collplant (nasdaq: clgn), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the nasdaq global market®  under the company's current ticker symbol "clgn" and will begin trading at the open of market on june 4, 2021. at such time, the company's american depositary shares (adss) will be mandatorily cancelled and exchanged for ordinary shares at a one-for-one ratio.
CLGN Ratings Summary
CLGN Quant Ranking